JP3136206B2 - ベンゾジオキサン誘導体 - Google Patents

ベンゾジオキサン誘導体

Info

Publication number
JP3136206B2
JP3136206B2 JP04278776A JP27877692A JP3136206B2 JP 3136206 B2 JP3136206 B2 JP 3136206B2 JP 04278776 A JP04278776 A JP 04278776A JP 27877692 A JP27877692 A JP 27877692A JP 3136206 B2 JP3136206 B2 JP 3136206B2
Authority
JP
Japan
Prior art keywords
compound
group
benzodioxane
amino
methylene chloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP04278776A
Other languages
English (en)
Japanese (ja)
Other versions
JPH069613A (ja
Inventor
章 香田
達雄 宮内
義剛 神辺
博一 濱田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP04278776A priority Critical patent/JP3136206B2/ja
Priority to TW081108332A priority patent/TW206222B/zh
Priority to CA002098821A priority patent/CA2098821C/en
Priority to AU27986/92A priority patent/AU2798692A/en
Priority to EP92922456A priority patent/EP0565732B1/en
Priority to AT92922456T priority patent/ATE162189T1/de
Priority to SG1996007484A priority patent/SG50640A1/en
Priority to KR1019930701929A priority patent/KR100217166B1/ko
Priority to ES92922456T priority patent/ES2112337T3/es
Priority to DE69224058T priority patent/DE69224058T2/de
Priority to PCT/JP1992/001366 priority patent/WO1993008182A1/ja
Publication of JPH069613A publication Critical patent/JPH069613A/ja
Priority to US08/369,924 priority patent/US5480905A/en
Application granted granted Critical
Publication of JP3136206B2 publication Critical patent/JP3136206B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Light Receiving Elements (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
JP04278776A 1991-10-22 1992-10-16 ベンゾジオキサン誘導体 Expired - Fee Related JP3136206B2 (ja)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP04278776A JP3136206B2 (ja) 1991-10-22 1992-10-16 ベンゾジオキサン誘導体
TW081108332A TW206222B (enExample) 1991-10-22 1992-10-20
DE69224058T DE69224058T2 (de) 1991-10-22 1992-10-21 Benzodioxanderivate
EP92922456A EP0565732B1 (en) 1991-10-22 1992-10-21 Benzodioxane derivative
AT92922456T ATE162189T1 (de) 1991-10-22 1992-10-21 Benzodioxanderivate
SG1996007484A SG50640A1 (en) 1991-10-22 1992-10-21 Benzodioxane derivatives
CA002098821A CA2098821C (en) 1991-10-22 1992-10-21 Benzodioxane derivatives
ES92922456T ES2112337T3 (es) 1991-10-22 1992-10-21 Derivado de benzodioxano.
AU27986/92A AU2798692A (en) 1991-10-22 1992-10-21 Benzodioxane derivative
PCT/JP1992/001366 WO1993008182A1 (fr) 1991-10-22 1992-10-21 Derive de benzodioxane
KR1019930701929A KR100217166B1 (ko) 1991-10-22 1992-10-21 벤조디옥산 유도체
US08/369,924 US5480905A (en) 1991-10-22 1995-01-06 Benzodioxane derivatives

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP27403691 1991-10-22
JP3-274036 1991-10-22
JP4-107570 1992-04-27
JP10757092 1992-04-27
JP04278776A JP3136206B2 (ja) 1991-10-22 1992-10-16 ベンゾジオキサン誘導体

Publications (2)

Publication Number Publication Date
JPH069613A JPH069613A (ja) 1994-01-18
JP3136206B2 true JP3136206B2 (ja) 2001-02-19

Family

ID=27311013

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04278776A Expired - Fee Related JP3136206B2 (ja) 1991-10-22 1992-10-16 ベンゾジオキサン誘導体

Country Status (12)

Country Link
US (1) US5480905A (enExample)
EP (1) EP0565732B1 (enExample)
JP (1) JP3136206B2 (enExample)
KR (1) KR100217166B1 (enExample)
AT (1) ATE162189T1 (enExample)
AU (1) AU2798692A (enExample)
CA (1) CA2098821C (enExample)
DE (1) DE69224058T2 (enExample)
ES (1) ES2112337T3 (enExample)
SG (1) SG50640A1 (enExample)
TW (1) TW206222B (enExample)
WO (1) WO1993008182A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3235448B2 (ja) * 1995-03-24 2001-12-04 ダイソー株式会社 １，４−ベンゾジオキサン誘導体の製法
EP0870757B1 (en) * 1997-04-10 2002-06-12 Pfizer Inc. Fluoro-substituted adamantane derivatives
US6020503A (en) * 1997-05-12 2000-02-01 Daiso Co., Ltd. Process for producing 1,4-benzodioxane derivatives
JP4604583B2 (ja) * 2004-07-20 2011-01-05 ダイソー株式会社 １−アミド−３−（２−ヒドロキシフェノキシ）−２−プロパノール誘導体、ならびに２−アミドメチル−１，４−ベンゾジオキサン誘導体の製造法
US8552078B2 (en) * 2006-10-17 2013-10-08 Air Products And Chemicals, Inc. Crosslinkers for improving stability of polyurethane foams
US8466296B2 (en) * 2007-03-26 2013-06-18 Ligand Pharmaceuticals Compounds and processes for preparing substituted aminomethyl-2,3,8,9-tetrahydro-7H-1,4-dioxino[2,3-e]indol-8-ones
GB201801130D0 (en) 2018-01-24 2018-03-07 Univ Oxford Innovation Ltd Compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR241161A1 (es) * 1984-07-30 1991-12-30 Merrelll Dow Pharmaceuticals I "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida"
US5010078A (en) * 1988-05-24 1991-04-23 American Home Products Corporation Aryl- and heteroaryl piperazinyl carboxamides having central nervous system activity
IL90279A (en) * 1988-05-24 1995-03-30 American Home Prod Piperazinyl carboxamide derivatives, their preparation and pharmaceutical com¦ositions containing them
US5036070A (en) * 1990-06-13 1991-07-30 American Home Products Corporation Polycyclic phenalkyl amines as psychotropic agents
US5126367A (en) * 1991-06-21 1992-06-30 American Home Products Corporation Psychotropic benzodioxan derivatives

Also Published As

Publication number Publication date
DE69224058D1 (de) 1998-02-19
KR100217166B1 (ko) 1999-09-01
DE69224058T2 (de) 1998-10-15
EP0565732B1 (en) 1998-01-14
WO1993008182A1 (fr) 1993-04-29
ES2112337T3 (es) 1998-04-01
EP0565732A4 (enExample) 1994-04-27
EP0565732A1 (en) 1993-10-20
CA2098821A1 (en) 1993-04-23
JPH069613A (ja) 1994-01-18
AU2798692A (en) 1993-05-21
CA2098821C (en) 2004-01-27
TW206222B (enExample) 1993-05-21
SG50640A1 (en) 1998-07-20
ATE162189T1 (de) 1998-01-15
US5480905A (en) 1996-01-02

Similar Documents

Publication Publication Date Title
RU2141959C1 (ru) Конденсированное бензосоединение и фармацевтическая композиция
TW577878B (en) A pharmaceutical composition having agonist-like activity selective at alpha 2B and 2B/2C adrenergic receptors
TWI236474B (en) Antagonists of MCP-1 function and methods of use thereof
JP3659969B2 (ja) 血管収縮性の置換アリールオキシアルキルジアミン類
JPH09503773A (ja) ５ｈｔ−１ｄレセプター拮抗剤用のベンズアニリド誘導体
CN101218223A (zh) 苯并二烷和苯并二氧戊环衍生物及其应用
FR2567885A1 (fr) Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
JPH09506884A (ja) ５ｈｔ▲下１ｄ▼アンタゴニスト活性を有するジヒドロベンゾフラニル−ビフェニルカルボキシアミド
PL174246B1 (pl) Nowe związki, pochodne benzocykloheptenu, benzoksepiny i benzotiepiny
JP3136206B2 (ja) ベンゾジオキサン誘導体
KR100860692B1 (ko) 축합 환식기를 가지는 환상 디아민 화합물
JPH09506885A (ja) ５ｈｔ▲下１ｄ▼（抗うつ作用）活性を有するインドール、インドリンおよびキノリン誘導体
EP0446921B1 (en) Optically active alkylene-dioxybenzene derivatives and their use in therapy
JP2868429B2 (ja) 新規アルキルアミノインダン化合物、その製造方法及びそれを含有する医薬組成物
WO2000058301A1 (fr) Derives de n-[2-(4-aminophenyl)ethyl]-2,3-dihydro-1,4-benzodioxine-2-methanamine, leur preparation et leur application en therapeutique
CA2090076A1 (en) Method for improving primary memory and/or learning
JP2002510682A (ja) うつ病治療用のインドール−３−イル−シクロヘキシルアミン誘導体（５−ｈｔ１受容体拮抗薬）
US5703239A (en) Indanylpiperidines as melatonergic agents
US6162803A (en) Indol-3-yl-cyclohexyl amine derivatives for the treatment of depression
JP2899433B2 (ja) アルキレンジオキシベンゼン誘導体およびそれを有効成分とする抗不安薬
US5234948A (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
JPH06293751A (ja) 光学活性ベンゾジオキサン誘導体並びにその化合物を含有する抗鬱剤及び抗不安剤
HU224310B1 (hu) 1,2-Dihidrociklobutabenzol-származékok, és az ezeket tartalmazó gyógyászati készítmények
JP3165409B2 (ja) アルキレンジオキシベンゼン誘導体を有効成分とする抗不安薬
JP2000502051A (ja) ５ｈｔ▲下１ｄ▼レセプターアンタゴニストとしての三環系スピロ化合物

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees